Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Core / Intermediate Bond · T. Rowe Price

MDVAX Performance & Returns History

Ticker MDVAX · · Holdings as of Jun 30, 2026

Expense ratio
1.09%$109/yr per $10k
5-yr return
−0.8%annualized
1-yr return
+3.8%as of Dec 2025
Net assets
$71.1Mall share classes
Holdings
359

Bottom line

How has MDVAX performed?

As of Dec 31, 2025, MDVAX returned +3.8% over the past year, −0.8% a year over five years, +2.0% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $12,200. Its five-year return beat 12% of core / intermediate bond funds we track.

Updated Dec 31, 2025

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
MDVAX+3.8%−0.8%+2.0%—
Core / Intermediate Bond median+7.2%+1.4%+3.0%—

Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending Jun 30, 2026, MDVAX returned +1.47%, +0.84%, +0.45% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.